← Eichor
Study identifier: NCT07231510 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Chlordecone Exposure and Female Fertility

Condition: Infertility Female  ·  Sponsor: Centre Hospitalier Universitaire de la Guadeloupe

PhaseN/A
Planned participants634
Who can joinFemale, 18 Years to 39 Years
Healthy volunteersNo

About this study

Chlordecone is an organochlorine pesticide used in the French West Indies (FWI) from 1972 to 1993 to control the banana root borer. Due to its very long persistence the population continues to be exposed to this chemical through their food consumptions. Although, chlordecone have been associated in animal study impairment of ovarian reserve, to date, no study has been published concerning the link between chlordecone exposure and female fertility. The main objective of this project is to study the association between chlordecone exposure and anti-mullerian hormone (AMH) in women consulting for couple infertility in Guadeloupe.

This description comes directly from the study's public registry record.

Talk to the study team

Mélanie petapermal  ·  +590590934667  ·  melanie.petapermal@chu-guadeloupe.fr

Valérie Hamony Soter  ·  +590590934677  ·  valerie.soter@chu-guadeloupe.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Chu de La GuadeloupePointe-à-Pitre, GuadeloupeRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07231510